Your search returned 3 results.

Results
	1.	Anti-PD-L1 Treatment Induced Central Diabetes Insipidus. MedStar authors: Kommalapati, Anuhya PMID: 29220526 Year: 2018 Citation: Journal of Clinical Endocrinology & Metabolism. 103(2):365-369, 2018 02 01. Institution: MedStar Washington Hospital Center Department: Medicine/Internal Medcine Medline publication type: Journal Article Form of publication: Journal Article All authors: Brownell I, Del Rivero J, Ebenuwa I, Gulley J, Kommalapati A, Strauss J, Tella SH, Zhao C DOI: https://dx.doi.org/10.1210/jc.2017-01905 Add to cart (remove)
	2.	Collaborative Multi-institutional Experience in Comparing PD-L1 Immunohistochemistry Assays: Concordance of SP142 and 22C3 Immunoreactivity. MedStar authors: Abdul Karim, Lina PMID: 29189261 Year: 2018 Citation: Applied Immunohistochemistry & Molecular Morphology. 26(2):e22, 2018 Feb Institution: MedStar Washington Hospital Center Department: Pathology Medline publication type: Journal Article Form of publication: Journal Article All authors: Abdul Karim L, Chahine JJ, Kallakury BVS, Ross JS, Sheehan CE DOI: https://dx.doi.org/10.1097/PAI.0000000000000609 Add to cart (remove)
	3.	Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors: Rao, Suman PMID: 30620668 Year: 2019 Citation: Journal of Clinical Oncology. 37(7):537-546, 2019 03 01. Institution: Medstar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J DOI: https://dx.doi.org/10.1200/JCO.18.00149 Add to cart (remove)

Powered by Koha